Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Orthofix Medical Q3 2026 Results: Net Loss of $6.07M, Loss Narrows

Orthofix Medical Inc. reported net sales of $207.9 million for the third quarter of 2026, a slight increase from $205.6 million in the prior year period. The company achieved a quarterly operating income of $1.5 million, a significant improvement from the $17.0 million operating loss in Q3 2025, though it still recorded a net loss of $6.1 million for the quarter.

Watch the Orthofix Medical Inc. earnings callFull call on the ALFA USA YouTube channel
Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue207.9205.6
Gross profit146.5148.5
Profit before tax-5.2-22.3
Net income-6.1-22.8
EPS (diluted, $ a share)$-0.15$-0.57

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+1.1%
Gross margin70.5%
Operating margin0.7%
Source

10-Q filed with the SEC, NASDAQ: OFIX. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Orthofix Medical Inc.: key numbers

Share price
$6.80Close, Nov 16
Market cap
$277M
Shares outstanding
40.76MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Orthofix Medical Inc.

All →
5:39 PM ET Form 4
Insider Buying

Orthofix Medical Insider Juniper Investment Company LLC Buys $5.11M of Stock

Juniper Investment Company LLC bought 689,803 shares of Orthofix Medical Inc. at $7.04 to $7.41 a share (average $7.40) in 2 transactions, worth $5.11M in total between Nov 9, 2026 and Nov 11, 2026. Shares held after the trade: 4,461,019 (+0.3%).

Value
$5.11M
Shares
689,803
Average price
$7.40
Holding change
+0.3%
Trade date
Nov 9, 2026 to Nov 11, 2026
8:01 AM ET 8-K
Financial Results

Orthofix Medical Financial Results

Orthofix Medical reported Q3 2026 net sales of $207.9 million, a 1% increase over the prior year, and a net loss of $6.1 million. The company revised its full-year 2026 revenue guidance downward to $825M-$830M to reflect weaker performance in its U.S. Spine business and ongoing efforts to improve commercial execution.

Term
Q3 2026

“Continued growth in Limb Reconstruction and Therapeutic Solutions helped offset weaker Spine performance. In U.S. Spine, we are accelerating actions to strengthen commercial execution, improve instrument set supply and allocation, and increase asset productivity by focusing resources on our highest-performing distributor partners, products and market opportunities.”

Massimo Calafiore, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.